Key result
Advanced imaging like CMR reclassifies the diagnosis in ~67% of MINOCA cases for personalized therapy.
Why the study?
MINOCA carries substantial morbidity and mortality, underscoring the need for accurate aetiological characterisation and tailored therapy using advanced imaging modalities.
Do advanced imaging modalities improve diagnosis, prognostic stratification, and therapeutic guidance in patients with MINOCA?
Population
Patients with MINOCA
Design
Literature review
Authors
Loading...
May support mechanism-guided MINOCA therapy; leaves open prospective trials on outcomes.
Do advanced imaging modalities improve diagnosis, prognostic stratification, and therapeutic guidance in patients with MINOCA?
Advanced imaging modalities such as CMR, OCT, and IVUS are essential for identifying the specific underlying mechanisms of MINOCA, thereby enabling personalized, mechanism-guided therapy.
Bozika et al. (2026) conducted a review in Myocardial infarction with non-obstructive coronary arteries (MINOCA). Advanced imaging modalities (CMR, OCT, IVUS, invasive functional testing) was evaluated. Advanced cardiac imaging modalities, such as CMR, reclassify the working diagnosis in up to two-thirds of MINOCA cases, transforming it into a mechanism-based syndrome for personalized therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: